ArticleCancer gene therapy2024

CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR.

Jaidev Bapat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.